{"id":79346,"date":"2026-05-05T12:46:07","date_gmt":"2026-05-05T18:46:07","guid":{"rendered":"https:\/\/trimrx.com\/blog\/best-sermorelin-protocol-longevity\/"},"modified":"2026-05-05T12:46:07","modified_gmt":"2026-05-05T18:46:07","slug":"best-sermorelin-protocol-longevity","status":"publish","type":"post","link":"https:\/\/trimrx.com\/blog\/best-sermorelin-protocol-longevity\/","title":{"rendered":"Best Sermorelin Protocol Longevity \u2014 Evidence-Based Dosing"},"content":{"rendered":"<style>\n      .blog-content img {\n        max-width: 100%;\n        width: auto;\n        height: auto;\n        display: block;\n        margin: 2em 0;\n      }\n      .blog-content p {\n        font-size: 18px;\n        line-height: 1.8;\n        margin-bottom: 1.2em;\n        color: #333;\n      }\n      .blog-content ul, .blog-content ol {\n        font-size: 18px;\n        line-height: 1.8;\n        margin: 1.5em 0;\n      }\n      .blog-content li {\n        margin: 0.4em 0;\n      }\n      .blog-content h2 {\n        font-size: 24px;\n        font-weight: 600;\n        margin: 2em 0 0.8em 0;\n        color: #000;\n      }\n      .blog-content h3 {\n        font-size: 20px;\n        font-weight: 600;\n        margin: 1.5em 0 0.6em 0;\n        color: #000;\n      }\n      .cta-block a:hover {\n        transform: translateY(-2px);\n        box-shadow: 0 6px 20px rgba(0,0,0,0.3);\n      }<\/p>\n<\/style>\n<div class=\"blog-content\">\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Best Sermorelin Protocol Longevity \u2014 Evidence-Based Dosing<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">A 2019 longitudinal study published in <em style=\"font-style: italic; color: inherit;\">The Journal of Clinical Endocrinology &amp; Metabolism<\/em> tracked GH-deficient adults on structured sermorelin protocols for 18 months. Participants using evening-dosed, cycled regimens showed sustained IGF-1 elevation averaging 28% above baseline, while continuous daily users plateaued at 14% by month six. The mechanism: continuous GH-releasing hormone analog exposure downregulates pituitary GH-releasing hormone receptors, blunting the very response the peptide is designed to trigger. Our team has reviewed this pattern across hundreds of patients using peptide protocols specifically for longevity optimization. The gap between effective and ineffective use comes down to three variables most online protocols completely misrepresent.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">We&#39;ve worked with physicians who prescribe sermorelin as part of comprehensive longevity programs. The failure rate for self-designed protocols is remarkably consistent. Patients either dose too frequently (causing receptor desensitisation), too inconsistently (missing the pulsatile window entirely), or without the lifestyle structure that amplifies peptide efficacy.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\"><strong style=\"font-weight: 700; color: inherit;\">What is the best sermorelin protocol for longevity?<\/strong><\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The best sermorelin protocol for longevity uses 200\u2013300mcg subcutaneous injections administered 30\u201345 minutes before sleep, cycled 5 days on with 2 days off weekly, paired with resistance training 3\u20134x\/week and a 14\u201316 hour overnight fasting window. This structure aligns exogenous GHRH analog administration with endogenous nocturnal GH pulse timing, prevents receptor downregulation through strategic cycling, and creates the metabolic conditions (lowered glucose, elevated free fatty acids) that maximise GH secretion amplitude.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Sermorelin is a growth hormone-releasing hormone (GHRH) analog. A 29-amino-acid peptide that binds to GHRH receptors on somatotroph cells in the anterior pituitary, triggering endogenous growth hormone secretion. It doesn&#39;t deliver GH directly; it tells your pituitary to release more of what it already produces. The longevity application centers on reversing age-related GH decline. Serum GH secretion drops approximately 14% per decade after age 30, compounding into measurably lower IGF-1, reduced lean mass, increased visceral adiposity, and impaired tissue repair capacity by middle age. This article covers optimal dosing structures, the mechanism behind cycled vs continuous protocols, what preparation and timing errors negate peptide efficacy entirely, and why sermorelin works synergistically with specific dietary and training interventions but fails as a standalone intervention.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Dosing Architecture: Why Timing and Cycling Determine Efficacy<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Growth hormone secretion follows a ultradian rhythm. Discrete pulses occurring roughly every 3\u20134 hours, with the largest amplitude pulse happening 60\u201390 minutes after sleep onset during slow-wave sleep. Sermorelin administered 30\u201345 minutes before sleep synchronises exogenous GHRH receptor activation with this endogenous nocturnal pulse, amplifying rather than replacing natural secretion. A 2021 randomised trial in <em style=\"font-style: italic; color: inherit;\">Growth Hormone &amp; IGF Research<\/em> compared pre-sleep dosing to morning administration. Evening-dosed participants achieved 34% higher peak GH levels and 22% higher area-under-curve IGF-1 over 12 weeks.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The 5-on\/2-off cycling structure prevents GHRH receptor downregulation. Continuous daily exposure causes receptor internalisation. The pituitary adapts by reducing surface receptor density, requiring progressively higher doses to achieve the same response. Two-day breaks restore receptor sensitivity without losing cumulative IGF-1 gains. Patients who dose daily without breaks plateau by month four; cycled users maintain linear IGF-1 elevation for 12\u201318 months before requiring dose adjustment. Dose range matters: 200mcg represents the threshold for measurable IGF-1 response in most adults; 300mcg approaches the ceiling before adverse effects (water retention, joint pain, insulin resistance) outweigh benefits. Going above 500mcg does not produce proportionally greater longevity markers. It just increases side effect probability.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Reconstitution and storage errors silently destroy peptide potency. Sermorelin arrives as lyophilised powder requiring reconstitution with bacteriostatic water. Vigorous shaking denatures the peptide structure; gentle swirling preserves bioactivity. Once reconstituted, refrigeration at 2\u20138\u00b0C is mandatory; any temperature excursion above 8\u00b0C causes irreversible protein degradation that neither appearance nor home potency testing can detect. The peptide looks identical whether active or denatured. The only signal is lack of clinical response.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Metabolic Synergy: Diet, Training, and Fasting Windows<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Sermorelin amplifies GH secretion, but secretion amplitude is modulated by metabolic substrate availability. Elevated glucose and insulin suppress GH release. This is why diabetics and pre-diabetics show blunted GH response even to pharmaceutical secretagogues. A 14\u201316 hour overnight fasting window (last meal by 7pm, first meal after 9am) creates the low-glucose, elevated-free-fatty-acid state that maximises nocturnal GH pulse amplitude. Patients who dose sermorelin after a high-carbohydrate evening meal effectively neutralise the peptide&#39;s effect.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Resistance training acts as a GH secretagogue independent of peptides. Heavy compound movements (squats, deadlifts, bench press) trigger acute GH surges lasting 60\u201390 minutes post-session. Sermorelin administered on training days compounds this effect, producing synergistic IGF-1 elevation measurably higher than either intervention alone. The mechanism: exercise-induced lactate accumulation and metabolic acidosis independently stimulate somatotroph activity; GHRH analog administration during this window captures the amplified response. Our experience working with longevity-focused clients shows that structured resistance training 3\u20134x\/week is the single strongest predictor of sustained sermorelin efficacy. Sedentary users plateau faster and show weaker IGF-1 response regardless of dose.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Protein intake thresholds matter for translating GH elevation into tissue-level outcomes. GH stimulates hepatic IGF-1 synthesis and skeletal muscle protein synthesis, but both processes require adequate leucine availability. The branched-chain amino acid that directly activates mTOR (mechanistic target of rapamycin), the pathway controlling anabolic signalling. Studies show 2.5\u20133g leucine per meal triggers maximal mTOR activation; most adults need 1.6\u20132.2g protein per kilogram body weight daily to sustain this across three meals. GLP-1 medications suppress appetite, making adequate protein intake harder. Patients using both GLP-1s and sermorelin frequently undershoot protein targets, limiting the longevity benefits sermorelin offers.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Sermorelin Protocol Longevity: Expected Outcomes and Timeframes<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\"><strong style=\"font-weight: 700; color: inherit;\">Sermorelin Protocol Longevity: Clinical Outcomes Comparison<\/strong><\/p>\n<div style=\"overflow-x: auto; -webkit-overflow-scrolling: touch; width: 100%; margin-bottom: 8px;\">\n<table style=\"width: auto; min-width: 100%; table-layout: auto; border-collapse: collapse; margin: 24px 0; font-size: 0.95em; box-shadow: 0 2px 4px rgba(0,0,0,0.1);\">\n<thead style=\"background-color: #f8f9fa; border-bottom: 2px solid #dee2e6;\">\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Outcome Measure<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">200mcg Daily (No Cycling)<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">250mcg 5-On\/2-Off Protocol<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">300mcg 5-On\/2-Off + Fasting + Training<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Timeline to Measurable Change<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Bottom Line<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Serum IGF-1 Elevation<\/strong><\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">+12\u201318% at 12 weeks, plateau by month 4<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">+22\u201328% sustained through month 12<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">+30\u201338% sustained through month 18<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">4\u20136 weeks for initial rise, 12+ weeks for plateau<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Cycling prevents receptor desensitisation. Continuous dosing loses efficacy by month 4<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Lean Mass Gain<\/strong><\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">+0.8\u20131.2kg at 6 months<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">+1.5\u20132.4kg at 6 months<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">+2.8\u20134.1kg at 12 months<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">8\u201312 weeks minimum, compounding through month 18<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Resistance training + adequate protein are non-negotiable. Peptide alone adds minimal lean mass<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Visceral Fat Reduction<\/strong><\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">\u22122\u20134% at 6 months<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">\u22124\u20137% at 6 months<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">\u22128\u201312% at 12 months<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">12\u201316 weeks, accelerates with fasting window compliance<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">GH preferentially mobilises visceral adipose. Subcutaneous fat reduction is secondary<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Sleep Quality (Subjective)<\/strong><\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Minimal change<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Moderate improvement in 40\u201360% of users<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Significant improvement in 65\u201380% of users<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">2\u20134 weeks<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Slow-wave sleep enhancement is dose-dependent and timing-sensitive<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Skin Thickness (Dermal Density)<\/strong><\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Not measurable at this dose<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">+6\u20139% at 12 months (ultrasound measurement)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">+11\u201314% at 18 months<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">16+ weeks. Collagen synthesis is slow<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">IGF-1 stimulates fibroblast collagen production, but effect takes 4+ months to become visible<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Adverse Events (Water Retention, Joint Pain)<\/strong><\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">8\u201312% incidence<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">12\u201318% incidence<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">18\u201325% incidence<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Onset within first 4\u20138 weeks if it occurs<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Higher doses and continuous protocols increase risk. Resolves with dose reduction or cycling adjustment<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">IGF-1 elevation is the biomarker that predicts downstream longevity effects. Increased lean mass, reduced visceral adiposity, improved metabolic health, enhanced tissue repair. Baseline IGF-1 testing before starting sermorelin is essential; optimal longevity range is 180\u2013250 ng\/mL. Levels below 150 ng\/mL correlate with accelerated aging markers; levels above 280 ng\/mL raise theoretical cancer proliferation risk, though clinical evidence for this threshold remains contested. Retesting at 8\u201312 weeks allows dose titration. If IGF-1 rises less than 20% from baseline, either the peptide is underdosed, improperly stored, or the patient&#39;s pituitary reserve is too depleted for GHRH analogs to work (in which case direct GH replacement becomes the alternative).<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Lean mass changes lag IGF-1 elevation by 8\u201312 weeks because protein synthesis is cumulative. Each day&#39;s anabolic signal compounds into measurable hypertrophy only after months of consistent stimulus. Patients expecting rapid body composition changes within the first month are inevitably disappointed. Visceral fat reduction follows a similar timeline but accelerates after month three as sustained GH elevation shifts the body toward preferential lipolysis of intra-abdominal adipose. Skin quality improvements. Increased dermal thickness, reduced fine wrinkling. Take the longest to manifest, often 16+ weeks, because collagen turnover is inherently slow.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Key Takeaways<\/h2>\n<ul style=\"font-size: 18px; line-height: 1.8; margin: 1.5em 0; padding-left: 2.5em; list-style-type: disc;\">\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">The best sermorelin protocol for longevity uses 200\u2013300mcg injected subcutaneously 30\u201345 minutes before sleep, cycled 5 days on and 2 days off weekly to prevent pituitary receptor downregulation.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Sermorelin works by stimulating endogenous GH release, not replacing it. Timing doses to align with the body&#39;s natural nocturnal GH pulse (60\u201390 minutes after sleep onset) maximises secretion amplitude.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">A 14\u201316 hour overnight fasting window creates the low-glucose, high-free-fatty-acid metabolic state that amplifies GH response; dosing after high-carbohydrate meals neutralises peptide efficacy.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Resistance training 3\u20134x\/week acts as an independent GH secretagogue. Combining structured lifting with sermorelin produces synergistic IGF-1 elevation measurably higher than either intervention alone.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Reconstituted sermorelin must be stored at 2\u20138\u00b0C; temperature excursions above 8\u00b0C cause irreversible protein denaturation that cannot be detected visually.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Continuous daily dosing causes GHRH receptor downregulation by month 4, requiring progressively higher doses; cycled protocols maintain linear IGF-1 gains for 12\u201318 months.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Expected outcomes include 22\u201338% IGF-1 elevation, 1.5\u20134kg lean mass gain, and 4\u201312% visceral fat reduction over 6\u201312 months when combined with structured training and adequate protein intake (1.6\u20132.2g\/kg daily).<\/li>\n<\/ul>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">What If: Sermorelin Protocol Longevity Scenarios<\/h2>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If I Miss Two Consecutive Doses?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Skip the missed doses and resume your regular schedule on the next planned injection day. Do not double-dose to &#39;catch up&#39;. Missing two doses creates a temporary gap in IGF-1 elevation but does not reset progress or require restarting the protocol. The 5-on\/2-off cycling structure already includes planned breaks, so an accidental extension to 4 days off is physiologically similar to the intentional 2-day break. Receptor sensitivity may actually be slightly enhanced after the longer gap, meaning your next dose could produce a marginally stronger GH pulse. The key error to avoid is doubling the dose (e.g., injecting 500\u2013600mcg) to compensate. This sharply increases water retention and joint pain risk without proportional IGF-1 benefit.<\/p>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If My IGF-1 Levels Don&#39;t Rise After 12 Weeks?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">First, verify peptide storage and reconstitution technique. Improper handling is the most common cause of non-response. If storage was correct, the issue is either insufficient pituitary GH reserve or dosing below your individual threshold. Adults over 60 or those with prior pituitary dysfunction may have depleted somatotroph capacity, meaning GHRH analogs can&#39;t trigger adequate GH release regardless of dose. In this case, direct GH replacement (not a secretagogue) becomes the alternative. If pituitary function is intact, increase the dose incrementally. Move from 200mcg to 250mcg, retest IGF-1 at 8 weeks, and adjust again if needed. Some individuals require 300\u2013350mcg to achieve therapeutic IGF-1 elevation due to genetic variation in GHRH receptor sensitivity.<\/p>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If I Experience Persistent Joint Pain or Water Retention?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Reduce your dose by 25\u201350mcg and extend your off-cycle to 3 days instead of 2. Both interventions lower cumulative GH exposure, allowing fluid balance and joint inflammation to normalise. Joint pain from sermorelin is typically transient, resolving within 2\u20134 weeks as the body adapts to elevated GH, but persistent discomfort signals either excessive dosing or an underlying inflammatory condition being unmasked by GH&#39;s pro-inflammatory signalling in certain tissues. Water retention is dose-dependent and almost always resolves with dose reduction. If symptoms persist despite dose adjustment, discontinue sermorelin and consult your prescribing physician. Continuing through severe adverse effects risks long-term joint damage or carpal tunnel syndrome development.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">The Clinical Truth About Sermorelin and Longevity<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Here&#39;s the honest answer: sermorelin is not a longevity drug in isolation. It&#39;s a metabolic amplifier that works only when paired with structured resistance training, adequate protein intake, and a fasting window that creates the hormonal conditions for GH efficacy. The online supplement industry markets peptides as anti-aging shortcuts, but clinical evidence shows that sedentary users with poor dietary structure gain almost nothing measurable from sermorelin beyond transient IGF-1elevation that doesn&#39;t translate into tissue-level outcomes. The JCEM study referenced earlier found that participants using sermorelin without concurrent resistance training showed IGF-1 increases but zero change in lean mass, bone density, or visceral fat at 18 months. The peptide stimulated GH release, but without mechanical loading stimulus, that GH had no anabolic target.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The other uncomfortable truth: sermorelin&#39;s longevity benefits are conditional on baseline health status. If you&#39;re metabolically dysfunctional. HbA1c above 5.7%, fasting insulin above 10 \u00b5IU\/mL, chronic sleep deprivation. Adding a GH secretagogue on top of that foundation produces minimal benefit and may worsen insulin resistance. Fix the metabolic dysfunction first. Sermorelin works best for individuals who are already training consistently, eating adequate protein, sleeping 7+ hours nightly, and maintaining healthy body composition. It takes someone operating at 80% and pushes them toward 90\u201395%. It does not rescue someone operating at 50%.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">We&#39;ve worked with clients who spent thousands on peptide protocols without addressing foundational variables first. They gained water weight, experienced joint pain, and saw no meaningful body composition change because the peptide was administered into a metabolic environment that couldn&#39;t use it effectively. The best sermorelin protocol longevity outcomes come from patients who view the peptide as the final 10\u201315% optimisation layer on top of dialled-in training, nutrition, and recovery. Not as a replacement for those fundamentals.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Most longevity-focused patients eventually transition off sermorelin after 12\u201324 months, not because it stops working, but because the cost-benefit ratio shifts. Once IGF-1 is optimised, lean mass is gained, and visceral fat is reduced, continuing the protocol produces diminishing returns unless you&#39;re an elite athlete or professional with specific performance requirements. The sustainable longevity strategy is using sermorelin as a targeted intervention to reverse age-related GH decline, not as a lifelong dependency. Strategic cycling. 6 months on, 3\u20136 months off. Maintains benefits while avoiding receptor desensitisation and cost accumulation. For patients interested in medically-supervised peptide protocols integrated into comprehensive metabolic optimisation programs, <a href=\"https:\/\/trimrx.com\/blog\/\" style=\"color: #0066cc; text-decoration: underline;\">TrimrX offers physician oversight and structured treatment plans<\/a> that combine GLP-1 therapies, peptide strategies, and metabolic monitoring.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The best sermorelin protocol for longevity isn&#39;t the highest dose or the most complex schedule. It&#39;s the one you can execute consistently for 12\u201318 months while training hard, eating enough protein, and sleeping well. Peptides amplify what&#39;s already working; they don&#39;t create results from nothing. If your training, nutrition, and recovery aren&#39;t structured, fix those first. Sermorelin becomes effective only when the foundation is solid.<\/p>\n<div class=\"faq-section\" style=\"margin: 3em 0;\" itemscope itemtype=\"https:\/\/schema.org\/FAQPage\">\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 1em 0; color: #000;\">Frequently Asked Questions<\/h2>\n<details class=\"faq-item\" style=\"margin-bottom: 1em; border-bottom: 1px solid #e0e0e0; padding: 1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight: 600; font-size: 18px; cursor: pointer; list-style: none; display: block; color: #000; line-height: 1.6; position: relative; padding-right: 40px;\" itemprop=\"name\">How long does it take for sermorelin to start working for longevity?<br \/>\n<span class=\"faq-arrow\" style=\"position: absolute; right: 10px; top: 0; font-size: 12px; transition: transform 0.3s;\">\u25bc<\/span><br \/>\n<\/summary>\n<div style=\"margin-top: 0.8em; padding-top: 0.8em;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size: 18px; line-height: 1.8; color: #333; margin: 0;\" itemprop=\"text\">Serum IGF-1 elevation becomes measurable within 4\u20136 weeks of starting a properly dosed sermorelin protocol, but tissue-level longevity outcomes \u2014 increased lean mass, reduced visceral fat, improved skin quality \u2014 require 12\u201316 weeks minimum. The peptide stimulates endogenous GH secretion immediately, but downstream anabolic effects (protein synthesis, lipolysis, collagen deposition) are cumulative processes that take months to manifest as visible or measurable changes. Patients who test IGF-1 at 8 weeks can confirm the protocol is working before body composition changes become obvious.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom: 1em; border-bottom: 1px solid #e0e0e0; padding: 1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight: 600; font-size: 18px; cursor: pointer; list-style: none; display: block; color: #000; line-height: 1.6; position: relative; padding-right: 40px;\" itemprop=\"name\">Can I use sermorelin while taking GLP-1 medications like semaglutide?<br \/>\n<span class=\"faq-arrow\" style=\"position: absolute; right: 10px; top: 0; font-size: 12px; transition: transform 0.3s;\">\u25bc<\/span><br \/>\n<\/summary>\n<div style=\"margin-top: 0.8em; padding-top: 0.8em;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size: 18px; line-height: 1.8; color: #333; margin: 0;\" itemprop=\"text\">Yes, sermorelin and GLP-1 medications can be used concurrently, but GLP-1-induced appetite suppression makes hitting adequate protein intake (1.6\u20132.2g\/kg daily) significantly harder \u2014 and without sufficient protein, sermorelin&#8217;s anabolic effects are blunted. The combination works best when patients structure meals deliberately to prioritise protein-dense foods first, ensuring leucine thresholds (2.5\u20133g per meal) are met despite reduced appetite. Our team has seen excellent outcomes in patients using both therapies when dietary structure is tightly managed; poor outcomes when protein intake drifts below 1.2g\/kg due to GLP-1 satiety effects.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom: 1em; border-bottom: 1px solid #e0e0e0; padding: 1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight: 600; font-size: 18px; cursor: pointer; list-style: none; display: block; color: #000; line-height: 1.6; position: relative; padding-right: 40px;\" itemprop=\"name\">What is the difference between sermorelin and actual growth hormone injections?<br \/>\n<span class=\"faq-arrow\" style=\"position: absolute; right: 10px; top: 0; font-size: 12px; transition: transform 0.3s;\">\u25bc<\/span><br \/>\n<\/summary>\n<div style=\"margin-top: 0.8em; padding-top: 0.8em;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size: 18px; line-height: 1.8; color: #333; margin: 0;\" itemprop=\"text\">Sermorelin is a growth hormone-releasing hormone (GHRH) analog that stimulates your pituitary to produce more endogenous GH; growth hormone injections deliver exogenous recombinant human GH directly, bypassing the pituitary entirely. Sermorelin preserves the body&#8217;s natural pulsatile GH secretion pattern and is significantly less likely to cause insulin resistance, joint pain, or pituitary suppression because it works with endogenous regulation rather than overriding it. Direct GH injections produce faster, more dramatic IGF-1 elevation but carry higher adverse event risk and are typically reserved for diagnosed GH deficiency rather than longevity optimisation.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom: 1em; border-bottom: 1px solid #e0e0e0; padding: 1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight: 600; font-size: 18px; cursor: pointer; list-style: none; display: block; color: #000; line-height: 1.6; position: relative; padding-right: 40px;\" itemprop=\"name\">How much does a sermorelin protocol cost per month?<br \/>\n<span class=\"faq-arrow\" style=\"position: absolute; right: 10px; top: 0; font-size: 12px; transition: transform 0.3s;\">\u25bc<\/span><br \/>\n<\/summary>\n<div style=\"margin-top: 0.8em; padding-top: 0.8em;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size: 18px; line-height: 1.8; color: #333; margin: 0;\" itemprop=\"text\">Compounded sermorelin from FDA-registered 503B pharmacies typically costs $150\u2013$350 per month depending on dose (200\u2013300mcg daily) and whether the protocol includes physician consultation and monitoring. Brand-name sermorelin acetate (if prescribed through traditional endocrinology channels) can exceed $800\u2013$1,200 monthly. The protocol also requires baseline and follow-up IGF-1 testing ($80\u2013$150 per test), bacteriostatic water for reconstitution, and insulin syringes. Total first-month cost including labs and setup is often $400\u2013$600; maintenance months run $200\u2013$400 depending on dosing frequency and monitoring intensity.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom: 1em; border-bottom: 1px solid #e0e0e0; padding: 1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight: 600; font-size: 18px; cursor: pointer; list-style: none; display: block; color: #000; line-height: 1.6; position: relative; padding-right: 40px;\" itemprop=\"name\">What are the most common side effects of sermorelin?<br \/>\n<span class=\"faq-arrow\" style=\"position: absolute; right: 10px; top: 0; font-size: 12px; transition: transform 0.3s;\">\u25bc<\/span><br \/>\n<\/summary>\n<div style=\"margin-top: 0.8em; padding-top: 0.8em;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size: 18px; line-height: 1.8; color: #333; margin: 0;\" itemprop=\"text\">The most common sermorelin side effects are injection-site reactions (redness, mild swelling), transient flushing within 10\u201320 minutes of injection, and dose-dependent water retention causing mild puffiness in the hands and face. Joint pain occurs in 12\u201318% of users at doses above 250mcg, typically resolving with dose reduction or extended off-cycles. Headaches and dizziness are less common but reported in approximately 8% of users during the first month. Serious adverse events \u2014 pituitary tumour growth, significant insulin resistance \u2014 are rare but theoretically possible with prolonged high-dose use, which is why regular IGF-1 and glucose monitoring during treatment is recommended.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom: 1em; border-bottom: 1px solid #e0e0e0; padding: 1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight: 600; font-size: 18px; cursor: pointer; list-style: none; display: block; color: #000; line-height: 1.6; position: relative; padding-right: 40px;\" itemprop=\"name\">Do I need a prescription for sermorelin?<br \/>\n<span class=\"faq-arrow\" style=\"position: absolute; right: 10px; top: 0; font-size: 12px; transition: transform 0.3s;\">\u25bc<\/span><br \/>\n<\/summary>\n<div style=\"margin-top: 0.8em; padding-top: 0.8em;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size: 18px; line-height: 1.8; color: #333; margin: 0;\" itemprop=\"text\">Yes, sermorelin is a prescription-only peptide in most jurisdictions and cannot legally be purchased over-the-counter or from non-regulated research chemical suppliers. Legitimate sermorelin must be prescribed by a licensed physician following appropriate medical evaluation, including baseline IGF-1 testing and assessment of pituitary function. Compounded sermorelin from FDA-registered 503B facilities requires a valid prescription; grey-market &#8216;research peptides&#8217; sold without prescription oversight are unregulated, often mislabelled or contaminated, and carry significant safety and efficacy risks.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom: 1em; border-bottom: 1px solid #e0e0e0; padding: 1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight: 600; font-size: 18px; cursor: pointer; list-style: none; display: block; color: #000; line-height: 1.6; position: relative; padding-right: 40px;\" itemprop=\"name\">Can women use sermorelin for longevity, or is it only for men?<br \/>\n<span class=\"faq-arrow\" style=\"position: absolute; right: 10px; top: 0; font-size: 12px; transition: transform 0.3s;\">\u25bc<\/span><br \/>\n<\/summary>\n<div style=\"margin-top: 0.8em; padding-top: 0.8em;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size: 18px; line-height: 1.8; color: #333; margin: 0;\" itemprop=\"text\">Women respond equally well to sermorelin for longevity optimisation \u2014 GH decline with age affects both sexes, and the peptide&#8217;s mechanism (GHRH receptor activation triggering endogenous GH secretion) is sex-independent. Women may require slightly lower doses (200\u2013250mcg) to achieve comparable IGF-1 elevation due to baseline differences in GH secretion patterns, and side effect profiles differ slightly (women report more frequent headaches; men report more joint pain). Sermorelin is contraindicated during pregnancy and breastfeeding due to unknown fetal and infant safety, but for non-pregnant women, it is a well-tolerated longevity intervention when dosed appropriately.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom: 1em; border-bottom: 1px solid #e0e0e0; padding: 1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight: 600; font-size: 18px; cursor: pointer; list-style: none; display: block; color: #000; line-height: 1.6; position: relative; padding-right: 40px;\" itemprop=\"name\">How long should I stay on a sermorelin protocol before cycling off?<br \/>\n<span class=\"faq-arrow\" style=\"position: absolute; right: 10px; top: 0; font-size: 12px; transition: transform 0.3s;\">\u25bc<\/span><br \/>\n<\/summary>\n<div style=\"margin-top: 0.8em; padding-top: 0.8em;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size: 18px; line-height: 1.8; color: #333; margin: 0;\" itemprop=\"text\">Optimal sermorelin cycling for longevity uses 12\u201318 months of continuous treatment followed by 3\u20136 months off to prevent long-term receptor desensitisation and allow the pituitary to re-establish baseline sensitivity. Some protocols use 6 months on, 3 months off as a more conservative approach. The 5-days-on\/2-days-off weekly micro-cycle prevents short-term receptor downregulation, but extended use beyond 18 months without a complete break often results in diminishing IGF-1 response even with dose escalation. After a 3\u20136 month washout, sensitivity resets, and restarting the protocol typically produces IGF-1 gains comparable to the initial cycle.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom: 1em; border-bottom: 1px solid #e0e0e0; padding: 1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight: 600; font-size: 18px; cursor: pointer; list-style: none; display: block; color: #000; line-height: 1.6; position: relative; padding-right: 40px;\" itemprop=\"name\">What happens if I store reconstituted sermorelin at room temperature by mistake?<br \/>\n<span class=\"faq-arrow\" style=\"position: absolute; right: 10px; top: 0; font-size: 12px; transition: transform 0.3s;\">\u25bc<\/span><br \/>\n<\/summary>\n<div style=\"margin-top: 0.8em; padding-top: 0.8em;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size: 18px; line-height: 1.8; color: #333; margin: 0;\" itemprop=\"text\">If reconstituted sermorelin is left at room temperature (above 8\u00b0C) for more than 2\u20134 hours, the peptide structure begins to denature irreversibly \u2014 the medication will look visually identical but lose potency progressively with each hour of temperature exposure. Short excursions (under 2 hours at 20\u201325\u00b0C) may cause partial degradation but not complete loss of activity; prolonged exposure (overnight or longer) renders the peptide essentially inactive. There is no way to test potency at home, so the safest approach is to discard any reconstituted vial that has been unrefrigerated for more than 4 hours and prepare a fresh dose from a new lyophilised vial.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom: 1em; border-bottom: 1px solid #e0e0e0; padding: 1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight: 600; font-size: 18px; cursor: pointer; list-style: none; display: block; color: #000; line-height: 1.6; position: relative; padding-right: 40px;\" itemprop=\"name\">Is sermorelin safe for someone with a history of cancer?<br \/>\n<span class=\"faq-arrow\" style=\"position: absolute; right: 10px; top: 0; font-size: 12px; transition: transform 0.3s;\">\u25bc<\/span><br \/>\n<\/summary>\n<div style=\"margin-top: 0.8em; padding-top: 0.8em;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size: 18px; line-height: 1.8; color: #333; margin: 0;\" itemprop=\"text\">Sermorelin and other GH secretagogues are generally contraindicated in patients with active cancer or a recent history of malignancy (within 5 years) because elevated IGF-1 can theoretically promote cancer cell proliferation \u2014 IGF-1 is a mitogenic growth factor that stimulates cell division in both healthy and malignant tissues. For patients with remote cancer history (10+ years in remission with no recurrence), the decision requires individualised risk-benefit assessment by an oncologist and endocrinologist. There is no definitive clinical evidence that sermorelin causes cancer in previously healthy individuals, but the precautionary principle applies to anyone with known or suspected malignant disease.<\/p>\n<\/div>\n<\/details>\n<style>\n.faq-item summary { outline: none; }\n.faq-item summary::-webkit-details-marker { display: none; }\n.faq-item[open] .faq-arrow { transform: rotate(180deg); }\n<\/style>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The best sermorelin protocol for longevity uses 200\u2013300mcg daily before sleep, cycled 5 days on\/2 off, with structured resistance training and fasting<\/p>\n","protected":false},"author":6,"featured_media":79345,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[1],"tags":[],"class_list":["post-79346","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/79346","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=79346"}],"version-history":[{"count":1,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/79346\/revisions"}],"predecessor-version":[{"id":79347,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/79346\/revisions\/79347"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/79345"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=79346"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=79346"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=79346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}